InsiderTrades.com logo
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol

TRML Insider Trading

Insider Ownership Percentage: 11.02%
Insider Buying (Last 12 Months): $3,321,997.59
Insider Selling (Last 12 Months): $0.00

Tourmaline Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Tourmaline Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tourmaline Bio Share Price & Price History

Current Price: $21.30
Price Change: ▲ Price Increase of +0.65 (3.15%)
As of 12/23/2024 06:27 PM ET

This chart shows the closing price history over time for TRML up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Could This Tiny Device Help You Make an Extra $30k a Year?
From Brownstone Research   |   Ad
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Click here to see the details because I believe a lot of people will get rich.

Tourmaline Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2024Sandeep Chidambar KulkarniCEOBuy5,221$13.79$71,997.595,221View SEC Filing Icon  
1/29/2024Mark McdadeDirectorBuy100,000$32.50$3,250,000.00448,431View SEC Filing Icon  
11/17/2023Parvinder ThiaraDirectorBuy1,000$17.31$17,310.0083,782View SEC Filing Icon  
11/17/2023Sandeep Chidambar KulkarniCEOBuy4,000$16.99$67,960.00729,735View SEC Filing Icon  
10/27/2023Caley CasteleinDirectorBuy15,800$14.55$229,890.00516,519View SEC Filing Icon  
10/26/2023Sandeep Chidambar KulkarniCEOBuy5,000$12.25$61,250.00725,735View SEC Filing Icon  
10/24/2023Aaron KantoffDirectorBuy7,500$11.86$88,950.0045,391View SEC Filing Icon  
10/24/2023Sandeep Chidambar KulkarniCEOBuy4,650$10.68$49,662.00720,735View SEC Filing Icon  
See Full Table
A Simple Trading Strategy You Should Know
From DTI   |   Ad
It’s no secret, I love big, juicy options trades. But when you’re chasing the BIG fish, you gotta have a way to target some steady, consistent returns in there as well. Check out the $100 Challenge This Chris Pulver, he’s isolated a way for everyday folks to target $100-$150 a day in the stock market, starting with just $1,000 or so. And while we cannot promise future returns or against losses, It’s the perfect supplement to more aggressive options strategies… And right now, everyone needs more cash in this economy.
So sign up for the $100 Challenge here

SEC Filings (Institutional Ownership Changes) for Tourmaline Bio (NASDAQ:TRML)

91.89% of Tourmaline Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TRML by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tourmaline Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC31,833$0.82M0.0%+283.7%0.124%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC482,078$12.40M0.0%+6.4%1.880%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC31,833$0.82M0.0%+283.7%0.124%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC21,705$0.56M0.0%-211.3%0.085%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP65,741$1.69M0.0%+72.8%0.256%Search for SEC Filing on Google Icon
11/15/2024State Street Corp411,980$10.59M0.0%+25.6%1.607%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.338,437$8.70M0.0%N/A1.320%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC332,095$8.54M6.9%+23.2%1.295%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC13,886$0.36M0.0%N/A0.054%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets13,348$0.34M0.0%-7.8%0.052%Search for SEC Filing on Google Icon
11/13/2024FMR LLC15,063$0.39M0.0%-93.6%0.059%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company8,804$0.23M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.63,571$1.63M0.0%+3.5%0.248%Search for SEC Filing on Google Icon
11/8/2024Jennison Associates LLC1,151,973$29.62M0.0%+2.2%4.493%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC9,381$0.24M0.0%+145.4%0.037%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC5,500$0.14M0.1%-92.7%0.021%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.4,932$0.13M0.0%+63.7%0.019%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC37,861$0.49M0.0%N/A0.148%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC39,866$0.51M0.0%+122.7%0.155%Search for SEC Filing on Google Icon
8/15/2024Blue Owl Capital Holdings LP1,715,401$22.06M6.2%+18.5%6.689%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC37,861$0.49M0.0%N/A0.148%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP170,447$2.19M0.0%+22.3%0.665%Search for SEC Filing on Google Icon
8/14/2024HighVista Strategies LLC83,397$1.07M0.4%+57.2%0.325%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC100,076$1.29M0.0%+184.9%0.390%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC3,822$49K0.0%+134.0%0.015%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers33,239$0.43M0.0%+28,554.3%0.130%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp70,697$0.91M0.0%N/A0.276%Search for SEC Filing on Google Icon
7/26/2024AlphaCentric Advisors LLC75,000$0.96M0.7%+22.7%0.292%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC33,666$0.43M0.0%N/A0.131%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.314,496$7.20M0.2%+244.0%1.226%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System14,578$0.33M0.0%N/A0.057%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC11,593$0.27M0.0%N/A0.045%Search for SEC Filing on Google Icon
5/15/2024Darwin Global Management Ltd.465,000$10.65M1.4%N/A1.813%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC2,222,222$50.89M0.6%+155.9%8.664%Search for SEC Filing on Google Icon
5/15/2024Altitude Crest Partners Inc.47,400$1.09M0.5%N/A0.185%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC50,000$1.15M0.1%-26.6%0.195%Search for SEC Filing on Google Icon
5/14/2024Qiming U.S. Ventures Management LLC741,691$16.99M18.9%+15.6%2.892%Search for SEC Filing on Google Icon
5/14/2024Nan Fung Group Holdings Ltd20,987$0.48M0.4%N/A0.082%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP274,219$6.28M1.7%N/A1.069%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.914,519$20.94M0.0%+19.7%3.566%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank32,000$0.73M0.0%N/A0.125%Search for SEC Filing on Google Icon
5/2/2024Jennison Associates LLC1,115,251$25.54M0.0%N/A4.348%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets1,346$31K0.0%N/A0.005%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.4,939$0.11M0.0%+109.5%0.019%Search for SEC Filing on Google Icon
4/19/2024Denali Advisors LLC5,600$0.13M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/15/2024Great Point Partners LLC672,885$17.62M3.0%N/A3.308%Search for SEC Filing on Google Icon
2/14/2024Braidwell LP906,820$23.74M0.9%N/A4.458%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC868,407$22.74M0.3%N/A4.269%Search for SEC Filing on Google Icon
2/14/2024RTW Investments LP398,850$10.44M0.2%N/A1.961%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC68,081$1.78M0.3%N/A0.335%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC14,500$0.38M0.0%N/A0.071%Search for SEC Filing on Google Icon
2/7/2024Vivo Capital LLC591,882$15.50M1.3%N/A2.910%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC245,500$6.43M4.9%N/A1.207%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tourmaline Bio logo
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.
Read More on Tourmaline Bio

Today's Range

Now: $21.30
Low: $20.44
High: $21.37

50 Day Range

MA: $25.42
Low: $19.87
High: $29.13

52 Week Range

Now: $21.30
Low: $12.12
High: $48.31

Volume

209,787 shs

Average Volume

291,821 shs

Market Capitalization

$546.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32

Who are the company insiders with the largest holdings of Tourmaline Bio?

Tourmaline Bio's top insider shareholders include:
  1. Sandeep Chidambar Kulkarni (CEO)
  2. Caley Castelein (Director)
  3. Mark Mcdade (Director)
  4. Parvinder Thiara (Director)
  5. Aaron Kantoff (Director)
Learn More about top insider investors at Tourmaline Bio.

Who are the major institutional investors of Tourmaline Bio?

Tourmaline Bio's top institutional shareholders include:
  1. Jennison Associates LLC — 4.49%
  2. Geode Capital Management LLC — 1.88%
  3. State Street Corp — 1.61%
  4. Point72 Asset Management L.P. — 1.32%
  5. Acuta Capital Partners LLC — 1.30%
  6. Wellington Management Group LLP — 0.26%
Learn More about top institutional investors of Tourmaline Bio stock.

Which major investors are selling Tourmaline Bio stock?

Within the last quarter, TRML stock was sold by these institutional investors:
  1. FMR LLC
  2. AlphaCentric Advisors LLC
  3. BNP Paribas Financial Markets

Which major investors are buying Tourmaline Bio stock?

Within the previous quarter, TRML stock was acquired by institutional investors including:
  1. Point72 Asset Management L.P.
  2. State Street Corp
  3. Acuta Capital Partners LLC
  4. Jane Street Group LLC
  5. Geode Capital Management LLC
  6. Wellington Management Group LLP
  7. Jennison Associates LLC
  8. Barclays PLC
In the previous year, these company insiders have bought Tourmaline Bio stock:
  1. Sandeep Chidambar Kulkarni (CEO)
  2. Caley Castelein (Director)
  3. Mark Mcdade (Director)
  4. Parvinder Thiara (Director)
  5. Aaron Kantoff (Director)
Learn More investors buying Tourmaline Bio stock.
We recommended Palantir in 2021, now we’re recommending this...
From Behind the Markets   |   Ad
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Click to get the name and ticker symbol